Analyst firms · Morgan Stanley · STAA

Morgan Stanley STAA price target and rating history

STAAR Surgical Company (STAA) · Health Care

Morgan Stanley rates STAAR Surgical Company (STAA) Underweight with a $13 price target, as of its latest action on Jan 16, 2026. It has published 3 rating actions on STAA since December 2023, including 0 upgrades and 1 downgrade. Across 5 firms with a STAA price target in the last 12 months, the median target is $27. Morgan Stanley's $13 is 52% below that.

Current rating
Underweight
Price target
$13
Median target, all firms
$27
Actions on STAA
3

Morgan Stanley price target on STAA

$37$25$13202420252026
Morgan Stanley price target on STAA, each point a stated target, December 2023 to January 2026.

Every Morgan Stanley rating on STAA

How other firms rate STAA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
StifelBuy$31Sep 29, 2026
UBSSell$20Jul 28, 2026
WedbushOutperform$40May 14, 2026
Canaccord GenuityBuy$27Apr 9, 2026
Morgan StanleyUnderweight$13Jan 16, 2026

Questions about Morgan Stanley and STAA

What is Morgan Stanley's price target for STAA?
Morgan Stanley's latest stated price target for STAAR Surgical Company (STAA) is $13, from its action on Jan 16, 2026.
What is Morgan Stanley's rating on STAA?
Morgan Stanley rates STAA Underweight, a bearish rating, as of Jan 16, 2026.
When did Morgan Stanley last change its view on STAA?
On Jan 16, 2026, Morgan Stanley resumes coverage at Underweight, price target $13.
How does Morgan Stanley's STAA target compare with other analysts?
Across 5 firms with a STAA price target in the last 12 months, the median target is $27. Morgan Stanley's $13 is 52% below that.

More STAA rating histories

All Morgan Stanley ratingsSTAA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.